Found 14 matching trials
Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction PHASE3 The purpose of this study is to determine if the combination of aspirin plu...
Show More Learn More & Join Trial
Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects PHASE1 Primary objective:
* Assess the effects of clopidogrel (300 mg loading dos...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO) PHASE2 PICOLO is a double blind placebo controlled phase II dose ranging, dose esc...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects PHASE1 Primary Objective:
* Investigate the possible role of the CYP2C19 genotype...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned PHASE3 Primary objective:
* To evaluate whether 12 weeks of clopidogrel is superi...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) PHASE3 RATIONALE:
* Atherothrombosis is a progressive and generalized vascular di...
Show More Location
The Cleveland Clinic Foundation
Learn More & Join Trial
Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation PHASE3 Contemporary management of cyanotic congenital heart disease includes three...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects PHASE1 Primary objective:
* Assess the effects of clopidogrel (600 mg loading dos...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS PHASE3 The purpose of this study is to evaluate whether a higher dosage of clopido...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation PHASE3 This study is the extension of the CLARINET study \[NCT00396877 -EFC5314\] ...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial